JC Partners joins bidders for KDB Life Insurance The Korean PE firm received access to a virtual data room to commence due diligence
Translated by Ryu Ho-joung 공개 2020-03-17 08:00:28
이 기사는 2020년 03월 17일 08시00분 thebell에 표출된 기사입니다
South Korea’s JC Partners has joined a race with two other bidders to buy KDB Life Insurance, though whether the firm will actually bid for the insurance company depends on the results of preliminary due diligence.The Seoul-based firm recently received access to a virtual data room (VDR) to commence due diligence on KDB Life Insurance, which state-run Korea Development Bank (KDB) put up for sale last year, sources close to the matter said on March 12.
KDB initially planned to sell the company by the end of last year, but the timeline for the sale ended up being postponed due to lukewarm investor interest. It was also partly because of Prudential Life Insurance, which surprised the market when it was put up for sale last December. As such, industry insiders were skeptical of a successful sale of KDB Life Insurance. But, with JC Partner joining other bidders, hopes are up that there could be a change in atmosphere.
Previously, KDB and its counsels – Credit Suisse and Samil PricewaterhouseCoopers – shortlisted two PE firms in the preliminary tender last December. They have since continued their marketing efforts toward other potential strategic and financial investors, hoping to increase the odds of a deal being signed. Such efforts seem to have borne fruit as JC Partners has expressed the intent to bid for the company.
It is difficult to predict how much a deal would be worth at this point, because, along with the sale of KDB’s existing stake in KDB Life Insurance, the deal would also likely entail an issue of fresh shares by the company to boost its capital. Deloitte Anjin is reportedly acting as financial advisor to JC Partners.
Still, many have doubts about whether KDB Life Insurance – which was acquired by a consortium of KDB and Consus Asset Management about ten years ago – would be able to find the new owner, given previous attempts at selling the company have all failed. Industry watchers say they need to wait and see how the situation plays out. KDB does not seem in a hurry to move to the next stage of the sale process, giving sufficient time to bidders to conduct due diligence.
“JC Partners, which is currently going through a regulatory process to become the largest shareholder in MG Non-life Insurance, is one of the PE firms that have great knowledge in the insurance industry,” an industry insider said. “But I think we need to wait and see how the situation evolves.”
(By reporter Rho Ar-rum)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [김화진칼럼]영국 RBS
- '환경 변화 고려' CJ제일제당, 그린바이오사업 계속 키운다
- [DN솔루션즈 IPO]고심끝 상장 철회…비우호적 시장 환경에 '결단'
- [i-point]신테카바이오, ‘2025 글로벌 IP 스타기업’ 선정
- [i-point]채비, 서울시 전기버스 충전 인프라 확대 사업자 선정
- [영상/Red & Blue]현대엘리베이터 '주주환원, 리포트, 실적' 삼박자
- 기지개 켜는 인성정보의 '헬스케어'
- [i-point]인텔리안테크, 정부 저궤도 위성통신망 구축 '핵심'
- [NHN 리빌딩]'아픈 손가락' 콘텐츠, 더디지만 잠재력 확신
- [영상]‘메타가 탐낸’ 퓨리오사AI의 백준호 대표에게 들었다…회사의 향후 계획은